Skip to Main content Skip to Navigation
Journal articles

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib

Sandra Lassalle 1, 2 Joséphine Zangari 1, 2 Alexandra Popa 3, 2, 4 Marius Ilie 1, 2, 5 Véronique Hofman 1, 2, 5 Elodie Long 6, 2, 5 Martine Patey 7 Frédérique Tissier 8 Geneviève Belleannée 9 Hélène Trouette 9 Bogdan Catargi 9 Isabelle Peyrottes 10, 2, 11 Jean-Louis Sadoul 12, 2, 5 Olivier Bordone 2, 5 Christelle Bonnetaud 5, 2 Catherine Butori 5, 2 Alexandre Bozec 2, 11, 1 Nicolas Guevara 13, 2 José Santini 11, 2 Imène Sarah Hénaoui 2, 14 Géraldine Lemaire 15, 2 Olivier Blanck 16 Philippe Vielh 17, 2 Pascal Barbry 18, 2 Bernard Mari 18, 2 Patrick Brest 19, 2, 1, 11 Paul Hofman 1, 2, 11, 20
Complete list of metadatas

https://hal.univ-cotedazur.fr/hal-02531830
Contributor : Patrick Brest <>
Submitted on : Friday, April 3, 2020 - 9:39:57 PM
Last modification on : Wednesday, August 19, 2020 - 11:18:59 AM

Links full text

Identifiers

Citation

Sandra Lassalle, Joséphine Zangari, Alexandra Popa, Marius Ilie, Véronique Hofman, et al.. MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib. Oncotarget, Impact journals, 2016, 7 (21), ⟨10.18632/oncotarget.8458⟩. ⟨hal-02531830⟩

Share

Metrics

Record views

61